Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
5
pubmed:dateCreated
1998-10-9
pubmed:abstractText
Cytoplasmic heart-type fatty acid-binding protein has recently gained much attention in clinical diagnosis as a very early marker of acute myocardial infarction. Immunoassays have been developed for determination of this protein in plasma and urine samples. In the present study it is shown that those types of fatty acid-binding proteins which are abundant in tissues other than heart and muscle do not interfere with immunochemical determination of heart-type fatty acid-binding protein. To provide sufficient protein of consistent quality as standard in these immunoassays, human heart-type fatty acid-binding protein was cloned, expressed in Escherichia coli and purified to homogeneity. For quantitation of the recombinant protein its extinction coefficient was determined. Comparison of the recombinant and tissue-derived proteins by a variety of methods revealed both proteins to show similar kinetic as well as equilibrium constants with respect to two monoclonal antibodies currently applied in immunochemical detection of heart-type fatty acid-binding protein. Both preparations were indistiguishable in sandwich-ELISA and immunosensor measurements. A high stability of the recombinant protein was proven by ELISA measurements during storage and several freeze and thaw cycles. Thus, recombinant and tissue-derived heart-type fatty acid-binding proteins are immunochemically equivalent. The recombinant human heart-type fatty acid-binding protein is now available as standard for immunoassays.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
May
pubmed:issn
1434-6621
pubmed:author
pubmed:issnType
Print
pubmed:volume
36
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
283-8
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed-meshheading:9676384-Antibodies, Monoclonal, pubmed-meshheading:9676384-Antigen-Antibody Reactions, pubmed-meshheading:9676384-Carrier Proteins, pubmed-meshheading:9676384-Cloning, Molecular, pubmed-meshheading:9676384-Cross Reactions, pubmed-meshheading:9676384-Drug Stability, pubmed-meshheading:9676384-Enzyme-Linked Immunosorbent Assay, pubmed-meshheading:9676384-Escherichia coli, pubmed-meshheading:9676384-Fatty Acid-Binding Proteins, pubmed-meshheading:9676384-Fatty Acids, pubmed-meshheading:9676384-Humans, pubmed-meshheading:9676384-Immunochemistry, pubmed-meshheading:9676384-Kinetics, pubmed-meshheading:9676384-Myelin P2 Protein, pubmed-meshheading:9676384-Myocardial Infarction, pubmed-meshheading:9676384-Myocardium, pubmed-meshheading:9676384-Neoplasm Proteins, pubmed-meshheading:9676384-Recombinant Proteins, pubmed-meshheading:9676384-Reference Standards, pubmed-meshheading:9676384-Tumor Suppressor Proteins
pubmed:year
1998
pubmed:articleTitle
Recombinant human heart-type fatty acid-binding protein as standard in immunochemical assays.
pubmed:affiliation
Institut für Chemo- und Biosensorik, Münster, Germany.
pubmed:publicationType
Journal Article, Comparative Study, In Vitro, Research Support, Non-U.S. Gov't